Selected article for: "case data and detailed case data"
Author: Nicolas Banholzer; Eva van Weenen; Bernhard Kratzwald; Arne Seeliger; Daniel Tschernutter; Pierluigi Bottrighi; Alberto Cenedese; Joan Puig Salles; Stefan Feuerriegel; Werner Vach
Title: Estimating the impact of non-pharmaceutical interventions on documented infections with COVID-19: A cross-country analysis
  • Document date: 2020_4_21
    • ID: mds06a8i_69
    Snippet: Our objective is to provide timely estimates that could inform health-policies. With more data becoming available, we may be able to refine our estimates. However, as many countries have implemented most measures already several weeks ago, increasing the observation period is of little informativeness. Additional information may arise from taking the federal structure of some countries into account (e.g., the United States and Germany), from more.....
    Document: Our objective is to provide timely estimates that could inform health-policies. With more data becoming available, we may be able to refine our estimates. However, as many countries have implemented most measures already several weeks ago, increasing the observation period is of little informativeness. Additional information may arise from taking the federal structure of some countries into account (e.g., the United States and Germany), from more detailed case data (e.g., recovery status or age), 16 All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • additional information and health policy: 1, 2
    • additional information and observation period: 1
    • case data and detailed case data: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • case data and health policy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • case data and health policy inform: 1, 2
    • case data and observation period: 1, 2, 3, 4
    • federal structure and health policy: 1
    • health policy and observation period: 1, 2, 3